🇪🇸 Spain · EU Public Tender
Suministro principio activo Ocrelizumab 300 mg, vial 10 ml perf. IV
🏛️ Dirección Gerencia del Complejo Hospitalario Universitario de Canarias · 📍 Santa Cruz de Tenerife
358 K€
Estimated value
—
Deadline
| Contract type | Supplies |
| CPV | 33690000 |
| Awarded to | Roche Farma, S. A. |
Full tender details, bidder list, market context and related contracts available below.
Data sourced from TED — the Official Journal of the EU.